Dr. Lal PathLabs has informed that, based on recommendations of Nomination & Remuneration Committee, the Board of Directors in their meeting held on March 17, 2024, approved the re-designation of Shankha Banerjee by appointing him as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP) with effect from May 21, 2024. The disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 and other applicable circulars, if any, is enclosed as ‘Annexure A’. Further, in view of above appointment and pursuant to Regulation 30(5) of Listing Regulations, the company has enclosed the details of the authorized persons for the purpose of determining materiality of any event or information, which shall be effective from May 21, 2024. Based on the decision of the above-named officials, the Compliance Officer shall be responsible for making disclosure to the Stock Exchange(s) and his contact details are also enclosed. The Board Meeting commenced at 11:00 am (IST) and concluded at 11:18 am (IST).
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7248.75 |
Max Healthcare Inst | 1166.60 |
Narayana Hrudayalay | 1286.30 |
Aster DM Healthcare | 486.85 |
Global Health | 1098.95 |
View more.. |